Psychopharmacotherapy of Pica- How Much Do We Know?

Abstract

There is little evidence for psychopharmacotherapy in pica. A few studies reported some benefit from the use of SSRIs, atypical antipsychotics and methylphenidate. That said, evidence to deploy these agents remains, at large, flimsy. Here, despite scarcity, we review available literature and draw some generalities that can inform decision-making on clinical grounds.

Keywords

ABA, antipsychotics, methyphenidate, pica, SSRIs

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In

Not yet subscribed? View subscription options

Purchase Article

Buy single-article access with a one-time purchase.

$30.00

Add to Cart

How to Cite

Ahmed Naguy, Nadyah Alayadhi, Soliman Al-Khadhari, Mohamed Y Abuzeid, Saxby Pridmore. Psychopharmacotherapy of Pica- How Much Do We Know?. Psychopharmacology Bulletin. 2024/08/19; 54(4):119-123. https://doi.org/10.64719/pb.4506